A new eye drug is now available to treat those who have age-related or diabetes-related vision loss. Developed by the Singapore Eye Research Institute and pharmaceutical firm Roche, it is the first to target both conditions together. The treatment also provides a longer-lasting remedy for patients.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
CNA Lifestyle: http://www.cnalifestyle.com